Cytek Biosciences (CTKB) Enterprise Value (2020 - 2025)
Cytek Biosciences' Enterprise Value history spans 6 years, with the latest figure at -$90.9 million for Q4 2025.
- For Q4 2025, Enterprise Value rose 7.99% year-over-year to -$90.9 million; the TTM value through Dec 2025 reached -$90.9 million, up 7.99%, while the annual FY2025 figure was -$90.9 million, 7.99% up from the prior year.
- Enterprise Value reached -$90.9 million in Q4 2025 per CTKB's latest filing, up from -$93.3 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$75.5 million in Q2 2025 to a low of -$364.6 million in Q4 2021.
- Average Enterprise Value over 5 years is -$197.7 million, with a median of -$163.6 million recorded in 2023.
- Peak YoY movement for Enterprise Value: tumbled 132.67% in 2022, then soared 62.42% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$364.6 million in 2021, then rose by 17.86% to -$299.5 million in 2022, then soared by 44.03% to -$167.6 million in 2023, then surged by 41.09% to -$98.7 million in 2024, then rose by 7.99% to -$90.9 million in 2025.
- Per Business Quant, the three most recent readings for CTKB's Enterprise Value are -$90.9 million (Q4 2025), -$93.3 million (Q3 2025), and -$75.5 million (Q2 2025).